Medsider Radio: Learn From Proven Medtech And Healthcare Experts

In this episode of Medsider Radio, we had an enlightening conversation with Ken Mariash, a leading figure in the neuromodulation space and the CEO of Sinaptica Therapeutics, where his team is developing groundbreaking treatments for Alzheimer's disease. Their device delivers non-invasive neuromodulation therapy to key networks of the brain and has shown unprecedented improvement in treating this debilitating disease. Ken's two decades of experience leading sophisticated organizations has taken him from management consulting at Charles River Associates to significant roles at CSL, Baxter, and Boston Scientific. During his time at Boston, Ken was instrumental in commercialization and strategy development in the company’s $1B neuromodulation division. In this interview, Ken shares his time-tested wisdom, covering a range of topics from kick-starting a venture and how to approach M&A transactions, to mastering commercialization and best practices for engaging with investors.Before we dive into the discussion,